Abstract
Exercise-induced bronchoconstriction (EIB) describes the transient narrowing of the airways during, and particularly after exercise and occurs commonly in asthmatic individuals. Limitation of exercise capacity is a frequent complaint in all age groups, and severity of EIB ranges from mild impairment of performance to severe bronchospasm and a large reduction in FEV1. Treatment of EIB varies from daily to less frequent therapy, depending on the level of activity. In this article, the authors evaluate the treatment possibilities before, during, and after exercise. They also review medications currently used to treat EIB.
Originalsprog | Engelsk |
---|---|
Tidsskrift | Immunology and Allergy Clinics of North America |
Vol/bind | 33 |
Udgave nummer | 3 |
Sider (fra-til) | 347-362 |
Antal sider | 16 |
ISSN | 0889-8561 |
DOI | |
Status | Udgivet - aug. 2013 |